• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18753 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2022     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) Treatment of postpartum depression
2007     Agency for Healthcare Research and Quality (AHRQ) Treatment of primary and secondary osteoarthritis of the knee
2007     Agency for Health Technology Assessment in Poland (AHTAPol) Treatment of pulmonary arterial hypertension in Poland - current practice. Survey results
2001     Agency for Healthcare Research and Quality (AHRQ) Treatment of pulmonary disease following cervical spinal cord injury
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment of renovascular hypertension - primary research
2018     Center for Evidence-based Practice (CEP) Treatment of severe acute medical-psychiatric comorbidity in hospitalized patients
2009     NIHR Health Technology Assessment programme Treatment of severe ankle sprain: a pragmatic randomised controlled trial comparing the clinical effecitveness and cost-effectiveness of three types of mechanical ankle support with tubular bandage. The CAST trial
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment of suppurative otitis media in young children - primary research
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Treatment of symptomatic pelvic vascular malformations
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Treatment of thoracic insufficiency syndrome with the vertical expandable prosthetic titanium rib
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment of varicose ulcer of the leg - primary research
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Treatment options for acoustic neuroma
1999     VA Technology Assessment Program (VATAP) Treatment options for male erectile dysfunction: a systematic review of published studies of effectiveness part 1 and part 2
2016     Agency for Healthcare Research and Quality (AHRQ) Treatment strategies for patients with lower extremity chronic venous disease (LECVD)
2013     Agency for Healthcare Research and Quality (AHRQ) Treatment strategies for patients with peripheral artery disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment strategies for patients with renal colic: a review of the comparative clinical and cost-effectiveness
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment strategies for rheumatoid arthritis - primary research
2012     Agency for Healthcare Research and Quality (AHRQ) Treatment strategies for women with coronary artery disease
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment strategy for chronic Hepatitis C - systematic review
2012     Agency for Healthcare Research and Quality (AHRQ) Treatment to prevent fractures in men and women with low bone density or osteoporosis: update of a 2007 report
1994     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Treatment with biosynthetic growth hormone in Turner syndrome- primary research
2003     Institute for Clinical Effectiveness and Health Policy (IECS) Treatment with interferon in hepatitis C
1997     The Swedish Council on Health Technology Assessment (SBU) Treatment with neuroleptics: SBU summary and conclusions
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Treatment with pegylated interferon in hepatitis C
2006     HAYES, Inc. Treatment with taxane agents (paclitaxel and docetaxel) for small cell lung cancer
2006     The Swedish Council on Health Technology Assessment (SBU) Treatment with vitamin D and calcium
2015     Agency for Healthcare Research and Quality (AHRQ) Treatments for ankyloglossia and ankyloglossia with concomitant lip-tie
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Treatments for benign prostatic hypertrophy
2008     HAYES, Inc. Treatments for binge eating disorder
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for constipation: a review of systematic reviews
2018     NIHR Health Technology Assessment programme Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review
2000     NIHR Health Technology Assessment programme Treatments for fatigue in multiple sclerosis: a rapid and systematic review
2016     Agency for Healthcare Research and Quality (AHRQ) Treatments for fecal incontinence
2015     Agency for Healthcare Research and Quality (AHRQ) Treatments for Fibromyalgia in Adult Subgroups
2016     NIHR Health Technology Assessment programme Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment
2011     Agency for Healthcare Research and Quality (AHRQ) Treatments for localized prostate cancer: systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation.
2017     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for locally advanced oropharyngeal cancer: a systematic review of clinical effectiveness and cost-effectiveness
2010     VA Technology Assessment Program (VATAP) Treatments for metastatic castrate-resistant prostate cancer
2004     Quality Improvement Scotland (NHS QIS ) Treatments for opiate dependence
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Treatments for patients with genotype 1 chronic hepatitis C: a review of evidence-based guidelines
2013     Agency for Healthcare Research and Quality (AHRQ) Treatments for seasonal allergic rhinitis
2003     NIHR Health Technology Assessment programme Treatments for spasticity and pain in multiple sclerosis: a systematic review
2013     NIHR Horizon Scanning Centre (NIHR HSC) Trebananib in combination with chemotherapy for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2009     HAYES, Inc. Trellis-8 Peripheral Infusion System (Bacchus Vascular Inc.) for deep vein thrombosis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Tremelimumab for unresectable pleural or peritoneal malignant mesothelioma – second and third line
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Treprostinil
2015     University of York Triage and minimising crowding in emergency departments
2010     The Swedish Council on Health Technology Assessment (SBU) Triage methods and patient flow processes at emergency departments
2021     Center for Evidence-based Practice (CEP) Triaging COVID-19 in the emergency department
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Triaging patients from the emergency department to other medical centres: a review of the clinical evidence and guidelines
2019     NIHR Health Technology Assessment programme Trial of Acute Femoral Fracture Fixation (TrAFFix). A feasibility study
2013     HAYES, Inc. Triangle tilt surgery for treatment of obstetric brachial plexus injury
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tricyclic antidepressants, clonidine, venlafaxine, and modafinil for the treatment of attention-deficit/hyperactivity disorder in adults: a review of the clinical evidence
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Tridimensional radiotherapy for breast cancer
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Trientine tetrahydrochloride (Cuprior®) [for] the treatment of Wilson's disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Trientine for treatment of Wilson's disease: clinical and cost-effectiveness, and safety
2009     HAYES, Inc. TriFlange acetabular prosthesis for failed total hip arthroplasty with massive acetabular defects
2016     HAYES, Inc. Trifluridine-tipiracil (Lonsurf) for refractory metastatic colorectal cancer
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Trigeminal nerve stimulation to treat neuralgia
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Trigger point injections for chronic non-malignant musculoskeletal pain
2009     HAYES, Inc. Trigger point injections for myofascial pain
2013     HAYES, Inc. Trigger point injections for myofascial pain
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Trigger point injections for non-malignant chronic pain
2010     Adelaide Health Technology Assessment (AHTA) Triggerfish continuous intraocular pressure monitoring system for the improved management of glaucoma patients
2022     Swiss Federal Office of Public Health (FOPH) Trimonthly vs. monthly use of bone-targeted agents in patients with bone metastases and multiple myeloma
2021     Austrian Institute for Health Technology Assessment (AIHTA) Triphasic biomaterial for augmentation of the osteoporotic femoral neck: systematic review
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Triple therapy for COPD
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for hepatitis C in previous non-responders: a review of the clinical effectiveness and safety
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for moderate-to-severe chronic obstructive pulmonary disease
2018     NIHR Health Technology Assessment programme Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
2019     Center for Evidence-based Practice (CEP) Triple-lumen peripherally-inserted central catheters
2000     British Columbia Office of Health Technology Assessment (BCOHTA) Triple-marker screening in British Columbia: current practice, future options
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for acute migraine: comparative clinical effectiveness and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Triptans for migraine headaches: a review of clinical evidence on safety
2016     NIHR Horizon Scanning Centre (NIHR HSC) Triptorelin (Decapeptyl SR) for premenopausal women with early endocrine responsive breast cancer
2011     HAYES, Inc. Trofile™ HIV tropism assay
1997     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Troglitazone for Type II diabetes
2008     NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) TruScan
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2006     National Institute for Health and Clinical Excellence (NICE) Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control
2010     HAYES, Inc. Tuberous Sclerosis Complex (TSC; Bourneville Disease)
2002     Health Technology Advisory Committee (HTAC) Tumescent liposuction
2001     HAYES, Inc. Tumescent liposuction
2011     HAYES, Inc. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2003     The Swedish Council on Health Technology Assessment (SBU) Tumor vaccination- early assessment briefs (Alert)
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Economic efficiency
2002     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Tumor-necrosis-factor alpha-antagonists in the treatment of rheumatoid arthritis - Medical efficacy
2016     NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2019     NIHR Health Technology Assessment programme Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis
2003     The Swedish Council on Health Technology Assessment (SBU) TUNA - Transurethral needle ablation for BPH - early assessment briefs (Alert)
2011     Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2014     Health Quality Ontario (HQO) Turning for the prevention and management of pressure ulcers: OHTAC Recommendation
2014     Health Quality Ontario (HQO) Turning for ulcer reduction (TURN) study: an economic analysis
2012     Medical Advisory Secretariat (MAS) Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis
2018     NIHR Health Technology Assessment programme Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
2020     NIHR Health Technology Assessment programme Two speeds of increasing milk feeds for very preterm or very low-birthweight infants: the SIFT RCT
2006     University HealthSystem Consortium (UHC) Tygacil
2002     HAYES, Inc. Tympanoplasty for recurrent and chronic otitis media
2017     Agency for Healthcare Research and Quality (AHRQ) Tympanostomy tubes in children with otitis media